Home Blog Page 756

Park Systems Opens New Global Headquarters, Launching a New Chapter in Nanometrology Leadership

GWACHEON, South Korea, April 7, 2026 /PRNewswire/ — Park Systems Corp., the world’s leading provider of atomic force microscopy (AFM) solutions, today announced the opening of its new global headquarters in Gwacheon city, South Korea. The new campus marks the culmination of three decades of growth and the beginning of a new phase of global expansion.

Park Systems' New Global Headquarters
Park Systems’ New Global Headquarters

The Gwacheon campus reflects Park Systems’ evolution from a Stanford-born research venture into a global leader in nanometrology. Located in Gwacheon Knowledge & Information Town near Seoul, the campus spans 27,000 square meters across 15 above-ground floors and 5 basement levels.

At the core of the facility is a basement-level industrial cleanroom with capacity for up to 35 industrial-grade metrology systems, designed to support the precision requirements of semiconductor fabrication and advanced packaging applications.

Dedicated research and demonstration labs provide a hands-on environment where customers can perform live measurements across Park Systems’ nanometrology portfolio—including AFM, imaging spectroscopic ellipsometry, and digital holographic microscopy—with direct support from application and engineering teams. More than 26% of the company’s global workforce is dedicated to R&D, a focus the new campus is designed to support and expand.

“For thirty years, we have pushed the limits of nanoscale measurement,” said Dr. Sang-il Park, Founder and CEO of Park Systems. “This new headquarters marks the beginning of our next phase of innovation as we continue to advance the boundaries of nanometrology.”

The Gwacheon headquarters also reflects Park Systems’ commitment to its people. Employee facilities include a fitness center, on-site childcare, a golf simulator lounge, and a cafeteria offering complimentary meals—supporting a work environment designed for long-term productivity and innovation.

Park Systems achieved a compound annual growth rate (CAGR) of 26% from 2015 to 2025 and was recognized as the global AFM market leader by MarketsandMarkets in its 2024 report, marking three consecutive years in the top position.

The company has been named to Forbes Asia’s Best Under a Billion list in 2020, 2023, and 2025, and has expanded its portfolio through the acquisitions of Accurion GmbH and Lyncée Tec SA.

ABOUT PARK SYSTEMS
Park Systems is a global leader in nanometrology, providing advanced measurement solutions for research and industrial applications. With regional offices across the Americas, Europe, and Asia, the company supports customers in semiconductor manufacturing, materials science, and nanotechnology research.

Its technology portfolio includes atomic force microscopy (AFM), imaging spectroscopic ellipsometry, digital holographic microscopy, white light interferometry, and active vibration isolation systems.

Founded by Dr. Sang-il Park, a contributor to the invention of AFM at Stanford University, the company has grown through continuous innovation and strategic acquisitions—including Accurion GmbH and Lyncée Tec SA—to lead the global nanometrology industry. Learn more at www.parksystems.com

From Festival to Framework: How Korea is Boosting Domestic Spending Through a Nationwide Shopping Event

  • A nationwide initiative is linking tourism, retail, and small businesses to turn local consumption into a coordinated economic stimulus

SEOUL, South Korea, April 7, 2026 /PRNewswire/ — Amid evolving global economic conditions, South Korea is exploring a distinctive approach to economic stimulus – one that goes beyond traditional fiscal or monetary measures, and instead focuses on mobilizing consumption.

Myeong-dong, one of the busiest shopping areas in Seoul
Myeong-dong, one of the busiest shopping areas in Seoul

At the center of this approach is the Donghaeng Festival (K-Shopping Festa or 동행축제 in Korean), a nationwide initiative led by Korea’s Ministry of SMEs and Startups, literally meaning a “shared journey” or collective participation. What began as a seasonal sales campaign has evolved into a nationwide mechanism designed to channel spending toward small businesses and local economies.

A Nationwide Consumption Framework

The April 2026 edition illustrates the scale of this effort. Over a 30-day period, the festival brings together more than 33,000 SMEs and micro businesses across approximately 200 distribution channels, while connecting consumption to more than 50 regional festivals nationwide.

Scale alone does not explain its significance.

The Donghaeng Festival operates as a coordinated system. Travel, cultural events, and retail promotions are not run in parallel – they are structurally linked. Visitors are drawn into regional areas through festivals and tourism programs, and that movement is then converted into local spending across traditional markets, neighborhood stores, and small business networks.

The result is a deliberate circulation of demand – redirecting consumption away from concentration in major urban centers toward a broader economic base.

Government as Market Catalyst

This level of coordination does not emerge organically. It is actively enabled by the government, which brings together central ministries, local authorities, and private-sector platforms into a single operational framework.

Rather than acting as a direct market participant, the state functions as a catalyst – aligning incentives, lowering participation barriers, and synchronizing fragmented actors. Discount schemes, digital vouchers, and partnerships with major retailers and financial institutions are designed to accelerate consumer spending while ensuring that it reaches smaller businesses.

In effect, policy is used not to replace the market, but to organize it.

Impact on Small Businesses

For small and micro enterprises, the effects are immediate.

Many operate with limited financial buffers, making short-term demand fluctuations critical. The festival creates concentrated periods of high visibility and purchasing activity, allowing businesses to generate revenue, improve cash flow, and stabilize operations within a relatively short timeframe.

This is particularly significant outside major metropolitan areas, where local businesses are more exposed to declines in foot traffic and consumer demand.

Measured Economic Effects

The economic impact is increasingly measurable.

In 2025, three rounds of the Donghaeng Festival generated substantial sales volumes:

  • KRW 313.5 billion (USD 209 million) in March
  • KRW 702.2 billion (USD 468 million) in May
  • KRW 1.39 trillion (USD 927 million) in September

Notably, indirect sales – reflecting spillover effects into surrounding commercial areas – account for a significant share of total activity. This suggests that the festival’s impact extends beyond official sales channels, stimulating broader local economies.

Local Economies, Tangible Effects

At the regional level, the outcomes are more modest in scale but highly concentrated.

Previous editions drew tens of thousands of visitors to local events, including around 18,000 visitors to Jeju Island, one of Korea’s primary tourism destinations, and approximately 9,000 visitors to Gwangju, a major regional city in the southwest.

For participating businesses, sales generated through these regional programs ranged from KRW 708 million (USD 470,000) to KRW 2.017 billion (USD 1.34 million) per cycle.

Such figures may appear limited in aggregate terms, but they represent meaningful gains for small merchants and local producers – where incremental revenue can directly affect business continuity.

Expanding Market Access

Another defining feature is the integration of distribution channels.

Participating firms are able to access a wide range of platforms simultaneously – from e-commerce and live commerce to department stores, hypermarkets, and convenience retail networks. This reduces structural barriers that typically limit small businesses’ access to larger markets.

The result is not just increased sales, but expanded visibility.

Beyond Short-Term Stimulus: A Model for Consumption-Led Growth

The Donghaeng Festival also serves a broader function in revitalizing domestic consumption. By aligning retail promotions with tourism and cultural experiences, it encourages both Korean consumers and international visitors to participate in local spending across regions.

For domestic households, the festival lowers the threshold for consumption through coordinated discounts and incentives, creating timely opportunities to re-engage with everyday spending. For international visitors, it offers structured entry points into Korea’s local economies – connecting travel experiences with neighborhood markets, regional products, and small businesses.

In this way, the initiative reinforces consumption not as a one-off response, but as a more sustained pattern of spending – linking short-term demand activation with a more resilient domestic consumption base.

Beyond its immediate impact, the model also carries broader policy implications on how consumption can be effectively mobilized.

The Donghaeng Festival demonstrates how domestic demand can be activated in a targeted and inclusive way – by integrating tourism, culture, and retail into a unified system that engages both residents and visitors. Rather than treating consumption as a passive outcome, it is actively designed and guided toward sectors and regions where its impact is most needed.

This approach builds growth not through isolated interventions, but through coordinated participation at scale – where individual spending, whether by local consumers or international tourists, contributes to a broader economic effect.

In a period defined by uncertainty, it offers a practical proposition: that strengthening domestic consumption – supported by both local demand and visitor spending – can provide a more stable foundation for economic resilience.

Rather than relying solely on large-scale policy shifts, the Donghaeng Festival suggests that growth can also be built through coordinated, everyday spending – distributed across regions, sectors, and communities.

PartnerOne Announces Chief Executive Officer to Lead Mortgage Cadence

RIVERSIDE, Calif., April 7, 2026 /PRNewswire/ — PartnerOne, one of the fastest-growing software groups in the world, has appointed Michael Detwiler as the new Chief Executive Officer for Mortgage Cadence.

PartnerOne recently acquired Mortgage Cadence, a leading provider of cloud-based digital lending solutions.

Mike is the original CEO and co-founder of Mortgage Cadence, building it into a leader in the mortgage industry. He is a very well-respected leader and a visionary executive with over 30 years of experience in mortgage lending software. After having grown Mortgage Cadence from its first steps in [2002] to 2015, Mike is back to lead it into the next decades of growth and innovation. He brings a strong record of scaling organizations, driving investments, and aligning people and technology to deliver a culture of customer centric success.

“I couldn’t be more enthusiastic about leading Mortgage Cadence as part of PartnerOne,” said Detwiler. “Our customers can plan on continued innovation in the age of AI and more importantly their being central to everything we do every day.”

“We are delighted to welcome Mike as our Mortgage Cadence CEO,” said Suzanne Fortman, Vice President at PartnerOne. “He brings a proven record of high performance and exemplary customer service that aligns seamlessly with PartnerOne’s fast-paced culture and long-term investment strategy. Mike is committed to building upon the company’s strong foundation, empowering teams, and driving sustainable growth as we continue to accelerate our momentum within the PartnerOne portfolio.” 

About PartnerOne 

PartnerOne is one of the fastest growing enterprise software groups in the world, with a proven track record of acquiring and growing enterprise software companies. Over 2000 enterprises and government organizations rely on PartnerOne software, including 80% of the largest companies in the world. With an “Acquire. Invest. Grow.” philosophy, PartnerOne provides a “forever-home” for acquired businesses and helps them thrive with shared resources and sustained investment. For more information, visit www.partnerone.com

About Mortgage Cadence 
Mortgage Cadence delivers the industry’s most complete, modern, cloud-based digital lending platform designed to provide an exceptional user experience throughout the entire mortgage lending life cycle, across all channels and products. With leading borrower point-of-sale through closing collaboration tools, the end-to-end platform is both complete and configurable, offering an open architecture designed to meet the needs of today’s lenders. The platform enables lenders to work more efficiently, leveraging automation and workflow tools that deliver excellent borrower, sales, and operational user experience. For more information, visit www.mortgagecadence.com. 

Billion Dollar Texas Real Estate Holding Announces AMASÉ- (ah-ma-Say)

Exclusive Luxury Rental Portfolio Launches Across Premier Global Destinations.  Family Office Appoints Dallas-Based Icon Global to Lead International Marketing Campaign

DALLAS, April 7, 2026 /PRNewswire/ — Amasé is a privately owned collection of exclusive luxury escapes in extraordinary places. Each residence is situated within destinations defined by landscape, culture and a distinct way of life informed by season and setting.

Aspen. Vail. Telluride. Hamptons. Jackson Hole. Santa Fe. Steamboat. Park City. Whitefish. Kauai. Maui. Belize. Bahamas …and more.

Amasé Director of Guest Experience, Robi Bhattacharya stated:

“Many of our locations are accessed via private FBO. Short-term rentals range from $5,000 to $40,000 per night with other non-published, fully private location options available for guests seeking complete anonymity. From private chefs and expert guides to fully customized concierge services, AMASÉ delivers tailored experiences — whether for intimate escapes, multi-family gatherings, or corporate retreats accommodating more than forty guests.”

The Amasé rollout will include high-profile activations in Dallas and Fort Worth, highlighted by its presence at the 2026 NCHA Celebrity Cutting, presented by Icon Global on Saturday, April 11, 2026.

This widely attended charitable event benefits UT Southwestern Medical Center and is co-chaired by Nicole Sheridan. It features professional cutting horse competitors paired with celebrity riders from husband, producer/director, Taylor Sheridan’s hit productions, including Landman, The Madison, Lioness, Mayor of Kingstown, Yellowstone, and more.

Simultaneously, AMASÉ will be showcased during the Longines FEI Jumping World Cup™ Finals and FEI Dressage World Cup™ Finals, taking place April 8–12 at Dickies Arena in Fort Worth.

The launch will also feature the Amasé retreats alongside Icon Global’s portfolio of premier ranches, polo properties, and equestrian estates. These will be presented within the exclusive Reliant Club, hosting international family offices, dignitaries, and high-net-worth clientele.

“The global communities within English and Western equestrian sport — including show jumping, dressage, cutting, and reining — along with international polo team owners and networks, represent a natural alignment with our target clientele.” added Bhattacharya.

Icon Global represents extraordinary people, who own extraordinary properties in extraordinary places.

“Amasé, (ah-ma -Say), which simply means ‘amazing’, is exactly that.” stated Icon Global’s Bernard Uechtritz. “This collection represents an extraordinary portfolio of architecturally significant, private legacy estates located in globally recognized resort destinations, as well as select, discreet off-market locations for those seeking complete privacy. With our deep expertise in marketing one-of-a-kind assets, Icon Global is proud to represent AMASÉ on the global stage.”

About Amase.

Amasé is a privately owned collection of luxury residences in extraordinary destinations.  Each home is situated within places shaped by landscape, culture, and a way of life defined by season and setting. Amasestays.com  

AMASÉ – all properties

AMASÉ + AN ICON GLOBAL ALLIANCE

AMASÉ + AN ICON GLOBAL ALLIANCE (60)

AMASÉ + AN ICON GLOBAL ALLIANCE (30)

About Icon Global 

Icon Global designs and implements strategic, tactical, national and global marketing campaigns for Iconic real estate, and additionally provides specialty advisory and portfolio services for owners of unique assets across the USA, parts of Europe, the Middle East and Asia. Icon represents banking and governmental institutions, and high net worth individuals’, as well as corporations and family offices globally, in the acquisition, management and disposition of property in all asset classes. Icon Global was founded by complex deal maker and International real estate advisor, Bernard Uechtritz.

TriNetX Enhances its Ability to Federate Genomics Data Across its Global Network of Providers through the Acquisition of Key Assets of Zetta Genomics

TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient care innovation

CAMBRIDGE, Mass. and CAMBRIDGE, United Kingdom, April 7, 2026 /PRNewswire/ — TriNetX, the world’s leading federated health data network, today announced that it has acquired the key assets of Zetta Genomics, a Cambridge, UK-based healthcare technology company and current TriNetX partner. The acquisition expands TriNetX’s genomics data management and analytics capabilities, supporting federated capture of multiomic data. This accelerates healthcare providers’ ability to integrate phenotypic and multiomic data for improved care delivery and clinical research and enhances the ability of TriNetX’s life science customers to perform large-data research in a cost-effective manner. 

Zetta’s flagship platform, XetaBase, is a multiomic capture and analytics platform designed for population‑scale genomic analysis. XetaBase is currently in use by leading healthcare provider organizations, life sciences companies, and research institutes.

TriNetX and Zetta have worked closely together since 2024 as part of TriNetX’s genomics data program. During this collaboration, the companies completed substantial technical feasibility work demonstrating secure, federated querying across genomic and phenotypic data to deliver high-integrity, analytically robust insights. This work establishes a strong foundation for further expansion.

“Through our partnership activities, led by our Chief Operating Officer Steve Kundrot and team, we have developed deep familiarity with Zetta’s leadership, technological prowess, and fit-for-purpose approach and have been consistently impressed with Zetta’s trusted healthcare provider relationships and robust analytics platform,” said Jeff Margolis, Executive Chairman of TriNetX. “Welcoming Zetta’s XetaBase platform into the TriNetX ecosystem represents an important milestone for our organization.”

Mr. Margolis continued, “This acquisition reflects our commitment to advancing multiomic-enabled research and supporting healthcare providers with a practical, localized approach to scaling their data infrastructures.”

Jeffrey Brown, PhD, TriNetX Chief Scientific Officer added, “Our purpose of driving better human health through data is clearly enhanced by adding the XetaBase technology, as we strongly believe the integration of different data types is essential to clinical and scientific progress.” 

“I am proud of what the Zetta team has built and excited to see XetaBase become part of the TriNetX array of data, software, and intelligence capabilities,” said Ignacio Medina Castello, Chief Executive Officer and Chief Technology Officer of Zetta Genomics. “From the beginning, our collaboration with TriNetX demonstrated that genomic and clinical data can be securely connected in a federated way at scale. Fully joining forces with TriNetX allows that work to move forward faster and to reach a broader global community of healthcare and research partners.”

About TriNetX, LLC

TriNetX is The Global Truth Engine for Better Human Health™, helping organizations understand what’s really happening in patient care. We connect health systems, researchers, and companies around the globe to real‑world patient data so they can make better‑informed decisions—based on reality, not assumptions.

Data is sourced directly from 11,000+ healthcare provider sites across more than 20 countries and kept within those institutions to protect accuracy, privacy, and trust. TriNetX combines this data with scientific expertise and technology to help customers ask better questions, interpret results, and move forward with confidence.

Learn more at trinetx.com or follow TriNetX on LinkedIn.

Media Contact
TriNetX
Karen Tunks
Email: Karen.Tunks@TriNetX.com

Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development

-Fixed–dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in their respective monotherapies in a head-to-head study. The fixed dose combination had excellent oral bioavailability, drug exposure and a half-life of up to 12 hours. These data support ASC30_39 FDC tablets as a potential novel one-pill-once-daily therapy for obesity. 

-ASC30_39 FDC demonstrated excellent compatibility between ASC30 and ASC39 when combined together, with room temperature stability and a small pill size.

-ASC30 is a Phase III-ready oral small molecule GLP-1R agonist that had a favorable gastrointestinal (GI) profile with half the rate of vomiting vs. orforglipron, when both drugs are dosed with weekly titration. 

-ASC39, an oral small molecule amylin-selective amylin receptor agonist, demonstrated eloralintide-like amylin selectivity and efficacy in preclinical models.

-Submission of an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) for ASC30_39 FDC oral tablets is expected in the third quarter of 2026.

HONG KONG, April 7, 2026 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) announces that it has selected ASC30_39 FDC, a fixed-dose combination (FDC) of ASC30, once-daily oral small molecule GLP-1R agonist and ASC39, once-daily oral small molecule amylin-selective amylin receptor agonist, for clinical development. Ascletis expects to submit an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) for ASC30_39 FDC oral tablets for the treatment of obesity in the third quarter of 2026.

ASC30_39 FDC tablets, dosed orally in dogs, demonstrated excellent oral bioavailability, high drug exposure and a long half-life of up to 12 hours. These key parameters of ASC30_39 FDC tablets are consistent with those observed in their respective monotherapies in a head-to-head dog study. Furthermore, ASC30_39 FDC tablets, developed utilizing Ascletis’ proprietary formulation technology, demonstrated a good compatibility between ASC30 and ASC39 with room temperature stability and a small pill size. The combination of the excellent pharmacokinetic profile of ASC30_39 FDC, the potential best- in-class efficacy and gastrointestinal (GI) tolerability of ASC30 and the first eloralintide-like small molecule amylin support ASC30_39 FDC tablets as a potential novel one-pill-once-daily therapy for the treatment of obesity.

ASC30 is a Phase III-ready oral small molecule GLP-1R agonist that had a favorable gastrointestinal (GI) profile with half the rate of vomiting vs. orforglipron, when both drugs are dosed with weekly titration in non-head-to-head studies (Press release).

As a clinical development candidate, ASC39 is a potent and amylin-selective oral small molecule amylin receptor agonist and demonstrated eloralintide-like amylin selectivity and efficacy in preclinical models.

“Selection of this fixed dose combination, which we believe is the first publicly announced co-formulation of an oral GLP-1 and an oral amylin, is an important step in the development of a new oral, potentially synergistic combination of ASC30 and ASC39 for the treatment of obesity,” said Jinzi Jason Wu, Ph.D., Founder, Chairman and CEO of Ascletis. “We believe this fixed dose combination, which combines the key features of high bioavailability, high drug exposure, a long half-life, and the convenience of a small pill, has the opportunity to improve patient outcomes for the treatment of obesity.”

About Ascletis Pharma Inc.

Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases. Utilizing its proprietary Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD) and Ultra-Long-Acting Platform (ULAP) technologies as well as Peptide Oral Transport ENhancement Technology (POTENT), Ascletis has developed multiple drug candidates in-house, including both small molecules and peptides, such as its lead program, ASC30, a small molecule GLP-1R agonist designed to be administered once daily orally and once monthly to once quarterly subcutaneously as a treatment therapy and a maintenance therapy for chronic weight management; ASC36, an amylin receptor peptide agonist, ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist and ASC37, a GLP-1R/GIPR/GCGR triple peptide agonist, and ASC39, a potent and amylin-selective oral small molecule amylin receptor agonist, for chronic weight management. Ascletis is listed on the Hong Kong Stock Exchange (1672.HK).

For more information, please visit www.ascletis.com.

Contact:
Peter Vozzo
ICR Healthcare
443-231-0505 (U.S.)
Peter.vozzo@icrhealthcare.com

Ascletis Pharma Inc. PR and IR Teams
+86-181-0650-9129 (China)
pr@ascletis.com
ir@ascletis.com

Jin Medical International Ltd. Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement

CHANGZHOU, China, April 7, 2026 /PRNewswire/ — Jin Medical International Ltd. (NASDAQ: ZJYL) (“Jin Medical”, and together with all its subsidiaries and consolidated entities, the “Company“), a NASDAQ-listed leading provider of rehabilitation medical equipment, today announced that it has received written notification from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement.

The Company regained compliance after its Class A ordinary shares maintained a closing bid price of at least $1.00 per share for more than ten (10) consecutive business days.

The Company will continue to focus on its core business operations and ongoing strategic initiatives.

About Jin Medical International Ltd.

Founded in 2006 and headquartered at Changzhou, Jiangsu Province of China, Jin Medical designs, develops, manufactures and markets wheelchairs and living aids products for people with disabilities, elderlies, and for rehabilitation application. Currently, Jin Medical already operates two manufacturing plants of approximately 230,000 square feet in the aggregate in Changzhou City and Taizhou City, Jiangsu Province, China. Jin Medical is currently establishing a new facility with 430,000 square feet in Chuzhou, Anhui Province, China. Jin Medical works with more than 40 distributors in China and more than 20 international distributors. The majority of Jin Medical’s wheelchair products, with more than 30 models, are sold to distributors in Japan and China. Jin Medical continuously delivers innovative wheelchair products that are both lightweight and ergonomic. For more information, please visit: http://www.jinmed.com.

Forward-Looking Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performances, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may”, “will”, “should”, “intend”, “plan”, “strive”, “believe”, “expect”, “anticipate”, “project”, “estimate,” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the following: the Company’s ability to achieve its goals and strategies, the Company’s future business development and plans for future business development, including its financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, import and export restrictions, fluctuations in general economic and business conditions, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission (“SEC“). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, as well as its current reports on Form 6-K and other filings, all of which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:
ir@jinmed.com

Cathay FHC advances AI Adoption across the group with OpenAI

TAIPEI, April 7, 2026 /PRNewswire/ — Cathay Financial Holdings (Cathay FHC) today announced a long-term strategic collaboration with OpenAI to strengthen the Group’s core capabilities in AI research, deployment, and governance. Cathay FHC is the first financial institution organization to work with OpenAI at this scale to bring AI advanced capabilities into its operations in Taiwan.

Cathay Financial Holdings announces a landmark long-term partnership with OpenAI, becoming the first financial institution in Taiwan to integrate advanced AI at this scale across research, deployment, and governance. (Resource: Cathay Financial Holdings)
Cathay Financial Holdings announces a landmark long-term partnership with OpenAI, becoming the first financial institution in Taiwan to integrate advanced AI at this scale across research, deployment, and governance. (Resource: Cathay Financial Holdings)

As artificial intelligence reshapes industries worldwide, financial institutions are increasingly exploring how advanced AI can transform internal operations, strengthen decision-making, and enhance customer services.

Under this agreement, Cathay FHC will deploy ChatGPT Enterprise across its subsidiaries and equip its employees with secure, enterprise-grade AI tools that are built with security and regulatory compliance. The roll-out will support teams in their day-to-day work while accelerating the development of new AI powered applications.

“Cathay FHC will leverage OpenAI’s technologies and engineering expertise to progressively introduce Agentic AI into our existing financial workflows. This will deepen intelligent and automated applications across business scenarios and support the transformation of our operating models,” said Marcus Lopez, Chief Technology Officer of Cathay Financial Holdings. “In addition, both parties will develop structured training and enablement programs to strengthen employees’ AI proficiency, enabling AI to become an effective digital teammate that elevates operational performance and modernizes workplace practices.”

“Cathay FHC has a clear vision for bringing advanced AI into the financial sector in a responsible and innovative way. We look forward to working together to roll out ChatGPT Enterprise and build secure, compliant solutions that help their teams move faster and deliver better outcomes for their customers,” said Oliver Jay, Managing Director, International of OpenAI.

A key focus of this collaboration is the creation of an enterprise-grade AI workstation that integrates OpenAI’s advanced large language model capabilities with Cathay FHC’s internal knowledge bases and proprietary intelligent agents. The platform will deliver a scalable, governable intelligent work environment and AI assistants for employees. It will enhance knowledge processing and day-to-day operations such as document summarization and rewriting, data synthesis, presentation generation, and operational inquiries. The workstation will also support natural-language-based code generation to accelerate engineering development and business automation. Secure integration with existing enterprise systems will further streamline workflow connectivity and improve information accessibility.

In addition to deploying ChatGPT Enterprise, Cathay FHC is also using OpenAI’s API to build new AI applications. Two initial initiatives focus on developing agentic AI systems for corporate banking and insurance. OpenAI will extend its technical experts to build an intelligent agent engine capable of multi-agent orchestration, along with a continuously evolving financial-domain knowledge system. These advancements will enhance operational efficiency while strengthening risk management and decision transparency, ensuring that all applications meet rigorous regulatory and compliance requirements.

Looking ahead, Cathay FHC will remain customer-centric and also advance an “AI as a Service” (AIaaS) approach, embedding AI significantly into employee workflows, service processes, and financial products. With a strong foundation of security and resilience, Cathay FHC will continue collaborating with strategic partners to shape a forward-looking, robust blueprint for next-generation digital finance.